Livzon Pharmaceutical Group Inc. (SHE:000513)
36.49
-0.26 (-0.71%)
Jun 6, 2025, 3:04 PM CST
SHE:000513 Revenue
Livzon Pharmaceutical Group had revenue of 3.18B CNY in the quarter ending March 31, 2025, a decrease of -1.92%. This brings the company's revenue in the last twelve months to 11.75B, down -4.16% year-over-year. In the year 2024, Livzon Pharmaceutical Group had annual revenue of 11.81B, down -4.97%.
Revenue (ttm)
11.75B
Revenue Growth
-4.16%
P/S Ratio
2.53
Revenue / Employee
1.30M
Employees
9,067
Market Cap
29.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.81B | -617.70M | -4.97% |
Dec 31, 2023 | 12.43B | -199.54M | -1.58% |
Dec 31, 2022 | 12.63B | 565.72M | 4.69% |
Jan 1, 2022 | 12.06B | 1.54B | 14.67% |
Jan 1, 2021 | 10.52B | 1.14B | 12.10% |
Jan 1, 2020 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Jan 1, 2018 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Aier Eye Hospital Group | 21.81B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |